These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 17381637)

  • 21. Coagulation defects do not predict blood product requirements during liver transplantation.
    Massicotte L; Beaulieu D; Thibeault L; Roy JD; Marleau D; Lapointe R; Roy A
    Transplantation; 2008 Apr; 85(7):956-62. PubMed ID: 18408574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in International Normalized Ratios After Plasma Transfusion of Varying Doses in Unique Clinical Environments.
    Warner MA; Hanson AC; Weister TJ; Higgins AA; Madde NR; Schroeder DR; Kreuter JD; Kor DJ
    Anesth Analg; 2018 Aug; 127(2):349-357. PubMed ID: 29596103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of fresh frozen plasma infusion in correction of coagulopathy of chronic liver disease: a dual phase study.
    Youssef WI; Salazar F; Dasarathy S; Beddow T; Mullen KD
    Am J Gastroenterol; 2003 Jun; 98(6):1391-4. PubMed ID: 12818286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An audit of fresh frozen plasma transfusion in intensive care patients.
    Gunawardana RH
    Ceylon Med J; 1996 Mar; 41(1):21. PubMed ID: 8754612
    [No Abstract]   [Full Text] [Related]  

  • 25. A national clinical scenario-based survey of clinicians' attitudes towards fresh frozen plasma transfusion for critically ill patients.
    Watson DM; Stanworth SJ; Wyncoll D; McAuley DF; Perkins GD; Young D; Biggin KJ; Walsh TS
    Transfus Med; 2011 Apr; 21(2):124-9. PubMed ID: 21062383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of a multi-center randomised clinical trial on prophylactic transfusion of fresh frozen plasma: implications for future trials.
    Müller MC; de Haan RJ; Vroom MB; Juffermans NP
    Transfus Med; 2014 Oct; 24(5):292-6. PubMed ID: 25202858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transfusion therapy in acquired coagulopathies.
    Humphries JE
    Hematol Oncol Clin North Am; 1994 Dec; 8(6):1181-201. PubMed ID: 7860444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Diagnosis and transfusion algorithm for the management of perioperative coagulopathy].
    Azma T; Yamasaki K; Mimasu M; Nakao M; Kikuchi H
    Masui; 2008 Sep; 57(9):1095-102. PubMed ID: 18807895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Indications of the different components of blood and outcome of transfusion practices in postpartum hemorrhage].
    Ricat R; Palot M
    Cah Anesthesiol; 1994; 42(3):385-9. PubMed ID: 7812867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thresholds for Perioperative Administration of Hemostatic Blood Components and Coagulation Factor Concentrates: An Unmet Medical Need.
    Bolliger D; Mauermann E; Tanaka KA
    J Cardiothorac Vasc Anesth; 2015; 29(3):768-76. PubMed ID: 26009289
    [No Abstract]   [Full Text] [Related]  

  • 31. Plasma and plasma products in the treatment of massive haemorrhage.
    Erber WN; Perry DJ
    Best Pract Res Clin Haematol; 2006; 19(1):97-112. PubMed ID: 16377544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elective fresh frozen plasma in the critically ill: what is the evidence?
    Verghese SG
    Crit Care Resusc; 2008 Sep; 10(3):264-8. PubMed ID: 18798728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for a rationale use of frozen plasma for the treatment and prevention of bleeding.
    Tinmouth A
    Transfus Apher Sci; 2012 Jun; 46(3):293-8. PubMed ID: 22521566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fresh frozen plasma: indications and risks. National Institutes of Health Consensus Conference.
    Transfus Med Rev; 1987 Dec; 1(3):201-4. PubMed ID: 2980280
    [No Abstract]   [Full Text] [Related]  

  • 35. Development and testing of freeze-dried plasma for the treatment of trauma-associated coagulopathy.
    Shuja F; Shults C; Duggan M; Tabbara M; Butt MU; Fischer TH; Schreiber MA; Tieu B; Holcomb JB; Sondeen JL; Demoya M; Velmahos GC; Alam HB
    J Trauma; 2008 Nov; 65(5):975-85. PubMed ID: 19001961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Status of "blood coagulation active human citrate plasma" within the scope of blood component therapy].
    Wegener S; Wilms K; Schlaack P; Roewer J
    Z Arztl Fortbild (Jena); 1987; 81(22):1151-4. PubMed ID: 3328435
    [No Abstract]   [Full Text] [Related]  

  • 37. Use of blood components in cancer patients with bleeding.
    Bodensteiner DC; Tilzer LL; Adams ME; Bayer WL
    Hematol Oncol Clin North Am; 1992 Dec; 6(6):1375-92. PubMed ID: 1452518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correcting haemostasis.
    Williamson LM
    Vox Sang; 2004 Jul; 87 Suppl1():51-7. PubMed ID: 15200605
    [No Abstract]   [Full Text] [Related]  

  • 39. [Dilutional coagulopathy: development, diagnostic options and management].
    Fries D
    Hamostaseologie; 2006 Aug; 26(3 Suppl 1):S15-9. PubMed ID: 16953287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fresh frozen plasma transfusion fails to influence the hemostatic balance in critically ill patients with a coagulopathy: reply.
    Müller MC; Juffermans NP
    J Thromb Haemost; 2015 Oct; 13(10):1943-4. PubMed ID: 26256567
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.